Splenic marginal zone B-cell lymphoma associated with ruptured breast implants: case report and review of the literature

References

• Cook PD, Osbourne BM, Connor RL, et al. Follicular lymphoma adjacent to foreign body granulomatous inflammation and fibrosis surrounding silicone breast prosthesis. Am J Surg Pathol. 1995;19(6):712–717.
   PubMed Web of Science ®Google Scholar
• Kraemer DM, Tony HP, Gattenlohner S, et al. Lymphoplasmacytic lymphoma in a patient with leaking silicone implant. Haematologica. 2004;89(4):ELT01.
   PubMedGoogle Scholar
• Nichter LS, Mueller MA, Burns RG, et al. First report of nodal marginal zone B-cell lymphoma associated with breast implants. Plast Reconstr Surg. 2012;129(3):576e–578e.
   PubMed Web of Science ®Google Scholar
• Moling O, Piccin A, Tauber M, et al. Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report. J Med Case Rep. 2016;10(1):254.
   PubMedGoogle Scholar
• Smith BK, Gray SS. Large B-cell lymphoma occurring in a breast implant capsule. Plast Reconstr Surg. 2014; 134(4):670e–671e.
   PubMed Web of Science ®Google Scholar
• Chen V, Hoang D, Clancy S. Breast implant-associated bilateral B-cell lymphoma. Aesthet Surg J. 2020;40(2):NP52–NP58.
   PubMed Web of Science ®Google Scholar
• Har-Shai L, Har-Shai Y, Metanes I, et al. Composite breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) and extra-nodal marginal zone lymphoma (MZL) in the capsule of a silicone breast implant. Autoimmun Rev. 2019;18(5):556–557.
   PubMed Web of Science ®Google Scholar
• Geethakumari PR, Markantonis J, Shah JL, et al. Breast implant-associated plasmablastic lymphoma: a case report and discussion of the literature. Clin Lymphoma Myeloma Leuk. 2019;19(10):e568–e572.
   PubMed Web of Science ®Google Scholar
• Evans MG, Miranda RN, Young PA, et al. B-cell lymphomas associated with breast implants: report of three cases and review of the literature. Ann of Diag Path. 2020;46:151512.
   PubMed Web of Science ®Google Scholar
• Jones JC, Chokshi S, Pistenmaa D, et al. Primary cutaneous follicle center lymphoma arising adjacent to silicone breast implant. Clin Breast Cancer. 2014;14(2):e65–e67.
   PubMedGoogle Scholar
• Larrimore C, Jaghab A. A rare case of breast implant-associated diffuse large B-cell lymphoma. Case Rep Oncol Med. 2019;2019:1801942.
   PubMed Web of Science ®Google Scholar
• Bennett M, Schechter GP. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab. Semin Hematol. 2010;47(2):143–147.
   PubMed Web of Science ®Google Scholar
• Schmid C, Kirkham N, Diss T, et al. Splenic marginal zone cell lymphoma. Am J Surg Pathol. 1992;16(5):455–466.
   PubMed Web of Science ®Google Scholar
• Matutes E, Oscier D, Montalban C, et al. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia. 2008;22(3):487–495.
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Felman P, Callet-Bauchu E, et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol. 2003;4(2):95–103.
   PubMed Web of Science ®Google Scholar
• Arcaini L, Lazzarino M, Colombo N, et al. Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood. 2006;107(12):4643–4649.
   PubMed Web of Science ®Google Scholar
• Chacón JI, Mollejo M, Munoz E, et al. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood. 2002;100(5):1648–1654.
   PubMed Web of Science ®Google Scholar
• Troussard X, Valensi F, Duchayne E, et al. Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Br J Haematol. 1996;93(3):731–736.
   PubMed Web of Science ®Google Scholar
• Iannitto E, Ambrosetti A, Ammatuna E, et al. Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients. Cancer. 2004;101(9):2050–2057.
   PubMed Web of Science ®Google Scholar
• Parry-Jones N, Matutes E, Gruszka-Westwood AM, et al. Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients. Br J Haematol. 2003;120(5):759–764.
   PubMed Web of Science ®Google Scholar
• Arcaini L, Orlandi E, Scotti M, et al. Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma. Clin Lymphoma. 2004;4(4):250–252.
   PubMedGoogle Scholar
• Mele A, Pulsoni A, Bianco E, et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood. 2003;102(3):996–999.
   PubMed Web of Science ®Google Scholar
• Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347(2):89–94.
   PubMed Web of Science ®Google Scholar
• Benavente Y, Mbisa G, Labo N, et al. Antibodies against lytic and latent Kaposi’s sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study. Br J Cancer. 2011;105(11):1768–1771.
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Felman P, Berger F, et al. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clin Lymphoma. 2002;3(1):41–47.
   PubMedGoogle Scholar
• Mendes J, Mendes Maykeh VA, Frascino LF, et al. Gluteal implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2019;144(3):610–613.
   PubMed Web of Science ®Google Scholar
• Shauly O, Gould DJ, Siddiqi I, et al. The first reported case of gluteal implant-associated anaplastic large cell Lymphoma (ALCL). Aesthet Surg J. 2019;39(7):NP253–NP258.
   PubMed Web of Science ®Google Scholar
• Laurent C, Haioun C, Brousset P, et al. New insights into breast implant-associated anaplastic large cell lymphoma. Curr Opin Oncol. 2018;30(5):292–300.
   PubMed Web of Science ®Google Scholar